Bioengineers in South Korea have succeeded in developing an intravenous needle (IV) that can bend and flex as it enters the human body. The softening IV needle is rigid at room temperature, similar to ...

Introduces the reader to a safe multiple agent IV sedation technique. Enables an increased understanding of the use of IV sedation in children. Removes the myth that IV sedation is a step lighter than ...

An intravenous (IV) injection is an injection of a medication or another substance into a vein and directly into the bloodstream. It is one of the fastest ways to get a drug into the body, often ...

Intravenous sedation with Midazolam is well established but is not suitable for all clinical situations. Patient-maintained sedation with propofol may offer an alternative to midazolam. The system is ...

Giving patients oral diazepam before they undergo cataract surgery, instead of running an intravenous (IV) drip with sedatives, can provide adequate, complication-free sedation, a single-center study ...

Some medications must be given by an intravenous (IV) injection or infusion. This means they’re sent directly into your vein using a needle or tube. In fact, the term “intravenous” means “into the ...

Woodcliff Lake, NJ - May 7, 2008 - Eisai Corporation of North America and its U.S. subsidiary, MGI PHARMA, INC., today announced that the U.S. Food and Drug Administration (FDA) Advisory Committee on ...

Inhaled isoflurane sedation was on par with IV midazolam for children age 3 to 17 years in the ICU on mechanical ventilation in a randomized trial. Isoflurane also reduced time to extubation and ...

There are many advantages to using local anesthesia with IV sedation during minimally invasive spinal procedures. Agnes P. Green, MD, a board certified anesthesiologist at The Bonati Spine Institute ...

WOODCLIFF LAKE, N.J., Nov. 16 Eisai Inc. today announced that LUSEDRA(TM) (fospropofol disodium) Injection is now available for use by persons trained in the administration of general anesthesia.

WOODCLIFF LAKE, N.J., Dec. 14 Eisai Corporation of NorthAmerica today announced that the U.S. Food and Drug Administration (FDA) hasapproved LUSEDRA(TM) (fospropofol disodium) Injection, an ...